Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dedu Honghua Qiwei is a traditional Chinese medicine (TCM) formulation, most commonly available as "Dedu Honghua Qiwei pills." It is used in the context of TCM for various health conditions, though specific indications are not detailed in the available literature. The formula likely contains a combination of seven herbal ingredients ("qiwei" means "seven flavors/ingredients"), with "honghua" referring to safflower (Carthamus tinctorius), which is often used in TCM to promote blood circulation and alleviate pain. The precise mechanism of action follows traditional Chinese medical theory rather than modern pharmacological targets; it may involve modulation of blood flow, anti-inflammatory effects, or other multi-target actions typical for complex herbal formulas. There is evidence that similar TCM formulations can improve clinical outcomes such as erectile function and testosterone levels without significant side effects[1]. However, no direct clinical trial data or modern pharmacological studies specific to Dedu Honghua Qiwei were identified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dedu honghua qiwei.